Intensive care unit-acquired weakness (ICUAW) of long-term survivors one to ten years after ICU-treatment.

Completed

• Conditions: ICU-acquired polyneuropathy; G62.80

• Registration Number: DRKS00011593
• Lead Sponsor: Klinik für Anästhesiologie, Intensiv-, Palliativ- und Schmerzmedizin; Berufsgenossenschaftliches Universitätsklinikum Bergmannsheil, Bochum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2017-01-19
• Study Completion: 2020-01-31
• Results First Posted: 2020-08-07
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 149

Inclusion Criteria

•age >/= 18 years
•voluntariness
•verbal declaration of consent after telephone enlightenment
•sufficient knowledge of German language
•>/= 7 days stay on an intensive care unit and at least 3 days of ventilation

Exclusion Criteria

•employees of the principal investigator or of the establishment, who/which is involved in trial
•participants who are not enlightenment capable because of verbal, psychic or somatic reasons
•missing declaration of consent

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Prevalence of ICUAW one to ten years after an ICU therapy

Secondary Outcome Measures

Name	Time	Method
•to determine the influence of an underlying disease and comorbidity of ICUAW<br>•to detect the impairment of life quality and daily life routine due to ICUAW<br>•to differentiate various symptoms (e.g. pain, sensory disturbance, motoric weakness) to be able to create a somatosensory profile<br>•to retrospectively detect risk factors which prevent/ facilitate the development or chronification of ICUAW<br>